Integrated Diagnostics Valuation
| IDHC Stock | 0.40 0.02 5.26% |
Integrated Diagnostics is overvalued. Integrated Diagnostics retains a regular Real Value of USD0.35 per share. The prevalent price of the firm is USD0.4. Our model calculates the value of Integrated Diagnostics from evaluating the firm fundamentals such as Return On Asset of 0.0969, return on equity of 0.23, and Current Valuation of 232.12 M as well as inspecting its technical indicators and probability of bankruptcy.
Price Book 4.1456 | Enterprise Value 232.1 M | Enterprise Value Ebitda 6.771 | Price Sales 0.049 | Forward PE 12.8866 |
Overvalued
Today
Please note that Integrated Diagnostics' price fluctuation is out of control at this time. Calculation of the real value of Integrated Diagnostics is based on 3 months time horizon. Increasing Integrated Diagnostics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Integrated stock is determined by what a typical buyer is willing to pay for full or partial control of Integrated Diagnostics Holdings. Since Integrated Diagnostics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Integrated Stock. However, Integrated Diagnostics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.4 | Real 0.35 | Hype 0.4 | Naive 0.43 |
The intrinsic value of Integrated Diagnostics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Integrated Diagnostics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Integrated Diagnostics Holdings helps investors to forecast how Integrated stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Integrated Diagnostics more accurately as focusing exclusively on Integrated Diagnostics' fundamentals will not take into account other important factors: Integrated Diagnostics Cash |
|
Integrated Diagnostics Total Value Analysis
Integrated Diagnostics Holdings is currently projected to have takeover price of 232.12 M with market capitalization of 23.25 B, debt of 1.18 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Integrated Diagnostics fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
232.12 M | 23.25 B | 1.18 B |
Integrated Diagnostics Investor Information
About 34.0% of the company shares are held by company insiders. The book value of Integrated Diagnostics was currently reported as 4.64. The company last dividend was issued on the 16th of June 2022. Integrated Diagnostics had 4:1 split on the 24th of December 2020. Based on the key indicators related to Integrated Diagnostics' liquidity, profitability, solvency, and operating efficiency, Integrated Diagnostics Holdings is performing exceptionally good at this time. It has a great probability to report excellent financial results in December.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 669.2 M | 543.7 M |
|
| |||||
| Operating Income | 765.5 M | 737.8 M |
|
|
Integrated Diagnostics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Integrated Diagnostics has an asset utilization ratio of 71.44 percent. This implies that the Company is making USD0.71 for each dollar of assets. An increasing asset utilization means that Integrated Diagnostics Holdings is more efficient with each dollar of assets it utilizes for everyday operations.Integrated Diagnostics Ownership Allocation
Integrated Diagnostics Holdings has a total of 581.33 Million outstanding shares. Integrated Diagnostics secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Integrated Diagnostics Profitability Analysis
The company reported the revenue of 4.12 B. Net Income was 737.36 M with profit before overhead, payroll, taxes, and interest of 2.8 B.About Integrated Diagnostics Valuation
The stock valuation mechanism determines Integrated Diagnostics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Integrated Diagnostics based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Integrated Diagnostics. We calculate exposure to Integrated Diagnostics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Integrated Diagnostics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.5 B | 1.1 B |
Additional Tools for Integrated Stock Analysis
When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.